Randomized Trial of Adult Participants With Generalized Anxiety Disorder

Summary

The purpose of this study is to compare the efficacy of troriluzole versus placebo in participants with generalized anxiety disorder.

Timeline

Start

2019-02-19

Primary completion

2020-01-14

Completion

2020-05-08

Outcome

Missed primary endpoint

registry analysis (superiority test); Troriluzole vs Placebo; p = 0.917; LS Mean Difference -0.07 (95% CI -1.45 to 1.30); Mixed Models Analysis NCT03829241 ↗

Drugs

Indications